BioSpace News Archive

Business

Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases

Mallinckrodt Chief Scientific Officer Steven Romano, M.D. joins Silence Board as non-executive Director

July 18, 2019
·
6 min read
Drug Development

CTI BioPharma Announces Outcome From End-of-Phase-2a Meeting With U.S. Food and Drug Administration (FDA) Regarding Pacritinib for Treatment of Myelofibrosis

Company Plans to Advance Pacritinib 200 mg Twice-Daily (BID) Dose to Phase 3 for Patients With Severe Thrombocytopenia

July 18, 2019
·
8 min read
Business

Immunocore and Pulse Infoframe, Inc. Partner with Leading Academic Institutions to Launch First Global Patient Registry for Uveal Melanoma

Patient-reported data will help inform research in rare form of eye cancer

July 18, 2019
·
5 min read
Drug Development

Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort

Moleculin Biotech, Inc., announced additional positive interim safety and efficacy data from its ongoing open label, single arm Phase 1/2 study of Annamycin in Poland.

July 18, 2019
·
5 min read
Business

Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors

Neuralstem, Inc. announced that Mary Ann Gray, Ph.D. has been appointed to the Company’s Board of Directors.

July 18, 2019
·
4 min read
Deals

DLH to Announce Third Quarter FY19 Financial Results

DLH Holdings Corp. announced that it will release its third quarter financial results for the period ended June 30, 2019 on August 5, 2019 after the market close.

July 18, 2019
·
1 min read
Business

Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

Bridge Biotherapeutics stands to receive up to more than EUR 1.1 billion assuming all milestones are met

July 18, 2019
·
3 min read
Business

Varex Subsidiary Direct Conversion Opens Application Innovation Centre In Munich

Varex Imaging Corporation announced that its Direct Conversion AB subsidiary has opened its Application Innovation Centre in Graefelfing, Munich, Germany.

July 18, 2019
·
3 min read
Deals

Elanco Finalizes Acquisition of Aratana Therapeutics

Elanco Animal Health Incorporated, finalized the acquisition of Aratana Therapeutics, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Galliprant®.

July 18, 2019
·
3 min read
Policy

/R E P E A T -- Government of Canada Launches Action Plan on Sexually Transmitted and Blood-Borne Infections/

Plan will accelerate efforts to prevent, diagnose and treat sexually transmitted and blood-borne infections, and address barriers to care

July 18, 2019
·
3 min read